In this research note, Redeye address some of the identified short case arguments circulating and discuss the share price collapse of 2025. In short, we find the presented arguments difficult to understand, and we underscore BONESUPPORT’s strong underlying business, which we believe is poised to be re-recognised, but is currently highly dependent on a shift in market sentiment.
LÄS MER
